The Role of Clinicians in Addressing the Opioid Overdose Epidemic
Date: Thursday, September 24, 2015
CDR, US Public Health Service
Director, Division of Science Policy
Office of the Assistant Secretary for Planning and Evaluation
U.S. Department of Health and Human Services
Departments of Environmental Health, Neurology, and Health Services
University of Washington
Washington State Department of Labor and Industries
Center for Substance Abuse Treatment
Substance Abuse & Mental Health Services Administration
U.S. Department of Health and Human Services
The nonmedical use of prescription opioids and the use of the illicit opioid heroin cause significant morbidity and mortality in the United States. Recent data indicate these public health problems are intertwined with one another and require a coordinated response between public health, healthcare providers, public safety, and the community. During this COCA Call, participants will learn about the drivers of the increases in opioid-related morbidity and mortality and steps clinicians can take to reverse these concerning trends.
- Review the epidemiology of opioid-related morbidity and mortality
- Describe the challenges of managing patients with pain conditions as well as patients who have opioid use disorders
- Discuss the FDA-approved treatments for opioid use disorders
- Discuss the steps that can be taken to improve opioid analgesic prescription for the treatment of pain
- Identify the steps that can be taken to incorporate opioid use disorder treatment into clinical practice
CDC Vital Signs and MMWR
- Today’s Heroin Epidemic
- Opioid Painkiller Prescribing – Where You Live Makes a Difference
- Prescription Painkiller Overdoses – A Growing Epidemic, Especially Among Women
- Vital Signs: Demographic and Substance Use Trends Among Heroin Users — United States, 2002–2013. Morbidity and Mortality Weekly Report (MMWR). July 10, 2015: 64(26), 719-725
CDC Injury Prevention and Control
- Prescription Drug Overdose: What Health Care Providers Need to Know about the Epidemic
- Safe Prescribing Tools for Health Care Providers
- Safer, More Effective Pain Management
- Prescription Drug Overdose Prevention for States
Other Agency Resources
- SAMHSA Opioid Overdose Toolkit
- The White House - Office of National Drug Control Policy: Opioid Abuse in the United States[471KB]
- Providers' Clinical Support System for Medication Assisted Treatment
- Providers' Clinical Support System for Opioid Therapies
- Office of the National Coordinator for Health Information Technology (ONC) - Linking PDMPs to Health IT
- National Action Plan for Adverse Drug Event Prevention
- CMS Improvements to Medicare Drug and Health Plans
- Audio conference call on 9/24/15: 2:00 - 3:00 PM
- Web-on-demand training after 3:00 PM on 9/24/15
- Materials: PowerPoint slide set
- Activity number:WCWD2286(SC)
- Date of origination/renewal:December 12, 2013
- Date of expiration:December 12, 2015
- To earn continuing education/contact hours
- Physician Assistants
- Health Educators
- Other Clinicians
- Contact Information:email@example.com
- Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communications Branch
- Method of Participation:You may participate in the educational activity by viewing the program information above.
- Fees:COCA continuing education credits are free.
CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Non-physicians will receive a certificate of participation.
CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity provides 1.0 contact hour.
CEU:The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 1.0 ANSI/IACET CEU's for this program.
CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1.0. CDC provider number GA0082.
CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 1.0 Contact Hour in pharmacy education. The Universal Activity Number is 0387-0000-15-161-L04-P and enduring 0387-0000-15-161-H04-P course category.
This program is knowledge based.
AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.2 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at firstname.lastname@example.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
DISCLOSURE:In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC does not accept commercial support.
- Page last reviewed: September 4, 2015
- Page last updated: September 22, 2015
- Content source:
- Maintained By: